gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NASDAQ · TMCIHealthcareSurgical Instruments

Treace Medical Concepts, Inc. Common Stock (TMCI)

$4.50+5.14%
Close Nov 4, 2026 · split-adjusted
Nov 4, 2026$4.50▼ 30.98% in range
Nov 4, 2025Low $1.20 · High $6.52Nov 4, 2026
What changed · written from our data
As of Nov 4, 2026

Treace Medical Concepts closed at $4.50 on Nov 4, up 5.14%, 31.7% below its 52-week closing high. Volume of 270.6K shares was 1.34× its 20-day average (above normal).

Split-adjusted performance: +12.5% over one month, +133.2% over six months, -31.7% over one year.

In the quarter ended Jun 30, 2026, revenue was $45.38M, down 4.2% from a year earlier, with a net margin of -35.0%.

Short interest was 1.9M shares at the Oct 15 settlement, down 2.7% from the prior report (4.0% of float, 8.3 days to cover).

Market cap$292.7M65.0M shares
Revenue · quarter$45.4M−4.2% YoY
Diluted EPS$-0.24—
P/E · TTM—P/S 1.4×
Net margin-35.0%Gross 78.5%
Dividend yieldNone
52-week range1.20 – 6.59−31.7% from high
Volume270.6K1.34× 20-day avg
Volatility · 60d61.0%Annualised
Short % of float4.0%8.3 days to cover
Net cash-$10.4MCash $45.6M
Next earnings—Not scheduled
Split-adjusted performance
1W −6.8%1M +12.5%3M +2.7%6M +133.2%YTD +83.7%1Y −31.7%3Y −53.5%5Y −80.5%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Surgical Instruments

Percentile among 110 companies (100 = best)

6-month momentum96
Revenue growth16
Net margin37
Value (low P/E)—
Size50

Industry medians: 6-month return −4.0%, revenue growth +8.9%, net margin −8.2%, P/E 30.5×.

Short interest

Details →
Shares short1.9M−2.7% vs prior
Days to cover8.3Settled Oct 15
% of float4.0%
Short vol. 10d24.3%of daily volume

Closest peers by size in Surgical Instruments

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
TMCITreace Medical Concepts$4.50+5.14%+133.2%−4.2%−35.0%—$292.7M
ANIKAnika Therapeutics$20.40+4.88%+34.9%+15.6%10.1%—$273.0MCompare
CLPTClearPoint Neuro$10.16+4.63%−11.4%+36.3%−61.8%—$325.7MCompare
INFUInfuSystem Holdings$13.15+2.73%+29.7%+2.6%8.7%30.7$261.9MCompare
PROFProfound Medical$7.16+2.43%−0.8%+12.3%−384.2%—$261.6MCompare
OSUROraSure Technologies$3.72+5.38%+24.0%−1.9%20.4%—$256.6MCompare
TLSITriSalus Life Sciences$3.89+11.78%−14.5%+1.7%−80.5%—$239.5MCompare
OBIOOrchestra BioMed Holdings$6.00+7.91%+46.0%−89.5%−27362.5%—$360.6MCompare
EMBCEmbecta$6.52+7.24%+83.1%−8.1%7.8%4.2$369.4MCompare

News about Treace Medical Concepts

All news →

No recent articles focused on Treace Medical Concepts. 2 articles mention it in passing.

Quick answers

What does Treace Medical Concepts do?
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities.
What is TMCI's market cap?
$292.66M, based on the Nov 4 close of $4.50.
Does Treace Medical Concepts pay a dividend?
No regular cash dividend has been paid in the last year.
How much of TMCI is sold short?
1.9M shares, 4.0% of float, as of Oct 15, 2026.
What sector is TMCI in?
Healthcare, in the Surgical Instruments industry.

About Treace Medical Concepts

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The company operates and manages its business as a single segment: designing, manufacturing, and marketing medical devices for surgeons, ambulatory surgery centers, and hospitals related to the surgical management of bunion and related midfoot deformities.

HQ: Ponte Vedra, FL450 employeesListed Apr 23, 2021treace.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology